FDA: FAERS Reports - Amtagvi (Lifileucel) (Oct 2024 - Present)

FDA: FAERS Reports - Amtagvi (Lifileucel) (Oct 2024 - Present)

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
Request Content: FAERS Reports: FDA FAERS reports on Amtagvi (lifileucel) from 10/1/24 to present, including report submission and adverse event dates.
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details